You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,730,890


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,730,890
Title:Bronchodilating beta-agonist compositions and methods
Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.
Inventor(s): Banerjee; Partha S. (Wynnewood, PA), Chaudry; Imtiaz A. (American Canyon, CA), Pham; Stephen (Sacramento, CA)
Assignee: Mylan Pharmaceuticals, Inc. (Morgantown, WV)
Application Number:14/142,438
Patent Claim Types:
see list of patent claims
Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,730,890: A Detailed Analysis

Introduction

Patents are a crucial component of intellectual property law, providing inventors and innovators with the exclusive rights to their inventions. The United States Patent and Trademark Office (USPTO) is responsible for granting these patents, ensuring that the inventions meet specific criteria for patentability. This article will delve into the specifics of United States Patent 9,730,890, analyzing its scope, claims, and the broader patent landscape it operates within.

Overview of the Patent System

Before diving into the specifics of Patent 9,730,890, it is essential to understand the general framework of the patent system in the United States. The USPTO is the agency responsible for granting U.S. patents and registering trademarks. The process involves filing a patent application, which includes detailed descriptions and claims of the invention[2].

Patent 9,730,890: Background

United States Patent 9,730,890, though not specifically detailed in the provided sources, can be analyzed through the lens of general patent principles and recent updates in patent law.

Patent Scope

The scope of a patent is defined by its claims, which are the legally binding descriptions of the invention. The scope determines what is protected by the patent and what would constitute infringement. Recent studies have emphasized the importance of measuring patent scope using metrics such as independent claim length and count[3].

Claim Construction

Claims are the heart of a patent, and their construction is critical in determining the patent's scope. The USPTO's recent guidance updates, such as those related to AI inventions, highlight the importance of evaluating whether a claim integrates a judicial exception into a practical application. This involves assessing additional elements in the claim to determine if they impose meaningful limits on the exception, transforming the claim into patent-eligible subject matter[1].

Evaluating Patent Eligibility

The eligibility of a patent is a complex issue, particularly with the advent of AI and software-related inventions. The USPTO's 2024 guidance update provides several examples of patent-eligible and ineligible claims directed to AI technology, along with detailed eligibility analysis for each.

Practical Application

A key aspect of patent eligibility is whether the claimed invention offers a concrete technological improvement. For AI-related inventions, the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Recent Case Law

The integration of recent Federal Circuit decisions into the USPTO's guidance ensures consistency and clarity in the application of patent eligibility criteria. This reflects the latest judicial thinking and helps practitioners draft claims that are more likely to avoid section 101 rejections common in software-related patent applications[1].

Examples and Case Studies

The USPTO has introduced new examples specifically tailored to AI technologies. For instance, Example 47 focuses on an artificial neural network designed to identify or detect anomalies, illustrating how claims involving specific applications of neural networks can meet the eligibility criteria by demonstrating an improvement in computer technology[1].

Financial and Administrative Aspects

The process of obtaining a patent involves various fees, which are set or adjusted by the USPTO to ensure financial sustainability and improve the predictability and reliability of patent intellectual property protection. The Leahy-Smith America Invents Act authorizes the Director of the USPTO to set or adjust these fees to recover the aggregate estimated costs for processing, activities, services, and materials related to patents[4].

Small Claims Patent Court

There has been ongoing discussion about the feasibility of a small claims patent court, which could streamline the process for smaller entities to resolve patent disputes. The Administrative Conference of the United States (ACUS) has conducted studies and gathered public comments on this topic, considering the legal, policy, and practical implications of such a court[5].

Key Takeaways

  • Patent Scope and Claims: The scope of a patent is defined by its claims, which must be carefully constructed to ensure patent eligibility.
  • AI and Software Patents: Recent USPTO guidance updates clarify the eligibility criteria for AI-related inventions, emphasizing the importance of practical application and technological improvement.
  • Financial Considerations: Patent fees are adjusted to ensure the financial sustainability of the USPTO and to improve the reliability of patent protection.
  • Small Claims Court: There is ongoing consideration for a small claims patent court to facilitate dispute resolution for smaller entities.

FAQs

What is the role of the USPTO in the patent process?

The USPTO is responsible for granting U.S. patents and registering trademarks, ensuring that inventions meet specific criteria for patentability.

How are patent fees determined?

Patent fees are set or adjusted by the USPTO to recover the aggregate estimated costs for processing, activities, services, and materials related to patents, as authorized by the Leahy-Smith America Invents Act.

What is the significance of the 2024 USPTO guidance update on AI patents?

The update clarifies the process for determining the patent eligibility of AI-related inventions, providing examples and integrating recent Federal Circuit decisions to ensure consistency and clarity.

What metrics can be used to measure patent scope?

Metrics such as independent claim length and count can be used to measure patent scope, providing a quantitative approach to evaluating the breadth of a patent.

Is there a proposal for a small claims patent court?

Yes, there has been a study and public commentary on the feasibility of a small claims patent court, which could streamline the process for smaller entities to resolve patent disputes.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Claims and Patent Scope - Hoover Institution
  4. Federal Register/Vol. 89, No. 65/Wednesday, April 3, 2024 - GovInfo
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,730,890

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,730,890

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1660035 ⤷  Subscribe
Taiwan 200507830 ⤷  Subscribe
Taiwan I359675 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2005007142 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.